These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1812747)
21. Dual inhibitors for aspartic proteases HIV-1 PR and renin: advancements in AIDS-hypertension-diabetes linkage via molecular dynamics, inhibition assays, and binding free energy calculations. Tzoupis H; Leonis G; Megariotis G; Supuran CT; Mavromoustakos T; Papadopoulos MG J Med Chem; 2012 Jun; 55(12):5784-96. PubMed ID: 22621689 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of cathepsin D by tripeptides containing statine analogs. Bessodes M; Antonakis K; Herscovici J; Garcia M; Rochefort H; Capony F; Lelièvre Y; Scherman D Biochem Pharmacol; 1999 Jul; 58(2):329-33. PubMed ID: 10423175 [TBL] [Abstract][Full Text] [Related]
23. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. Lam PY; Jadhav PK; Eyermann CJ; Hodge CN; Ru Y; Bacheler LT; Meek JL; Otto MJ; Rayner MM; Wong YN Science; 1994 Jan; 263(5145):380-4. PubMed ID: 8278812 [TBL] [Abstract][Full Text] [Related]
24. Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. DesJarlais RL; Seibel GL; Kuntz ID; Furth PS; Alvarez JC; Ortiz de Montellano PR; DeCamp DL; Babé LM; Craik CS Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6644-8. PubMed ID: 2204060 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. Perno CF; Bergamini A; Pesce CD; Milanese G; Capozzi M; Aquaro S; Thaisrivongs S; Tarpley WG; Zon G; D'Agostini C J Infect Dis; 1993 Nov; 168(5):1148-56. PubMed ID: 8228348 [TBL] [Abstract][Full Text] [Related]
26. An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection. Ashorn P; McQuade TJ; Thaisrivongs S; Tomasselli AG; Tarpley WG; Moss B Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7472-6. PubMed ID: 2217178 [TBL] [Abstract][Full Text] [Related]
27. Synthetic, structural mimetics of the β-hairpin flap of HIV-1 protease inhibit enzyme function. Chauhan J; Chen SE; Fenstermacher KJ; Naser-Tavakolian A; Reingewertz T; Salmo R; Lee C; Williams E; Raje M; Sundberg E; DeStefano JJ; Freire E; Fletcher S Bioorg Med Chem; 2015 Nov; 23(21):7095-109. PubMed ID: 26474665 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV-1 protease by short peptides derived from the terminal segments of the protease. Schramm HJ; Breipohl G; Hansen J; Henke S; Jaeger E; Meichsner C; Riess G; Ruppert D; Rücknagel KP; Schäfer W Biochem Biophys Res Commun; 1992 Apr; 184(2):980-5. PubMed ID: 1575762 [TBL] [Abstract][Full Text] [Related]
30. A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. McQuade TJ; Tomasselli AG; Liu L; Karacostas V; Moss B; Sawyer TK; Heinrikson RL; Tarpley WG Science; 1990 Jan; 247(4941):454-6. PubMed ID: 2405486 [TBL] [Abstract][Full Text] [Related]
31. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016 [TBL] [Abstract][Full Text] [Related]
32. Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor. Schimer J; Pávová M; Anders M; Pachl P; Šácha P; Cígler P; Weber J; Majer P; Řezáčová P; Kräusslich HG; Müller B; Konvalinka J Nat Commun; 2015 Mar; 6():6461. PubMed ID: 25751579 [TBL] [Abstract][Full Text] [Related]
33. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus. Grobelny D; Wondrak EM; Galardy RE; Oroszlan S Biochem Biophys Res Commun; 1990 Jun; 169(3):1111-6. PubMed ID: 2114105 [TBL] [Abstract][Full Text] [Related]
34. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir. Lefebvre E; Schiffer CA AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715 [TBL] [Abstract][Full Text] [Related]
35. New cathepsin d inhibitors with hydroxyethylamine isosteres: preparation and characterization. McConnell RM; Green AW; Trana CJ; McConnell MS; Lindley JF; Sayyar K; Godwin WE; Hatfield SE Med Chem; 2006 Jan; 2(1):27-38. PubMed ID: 16787353 [TBL] [Abstract][Full Text] [Related]
36. The three-dimensional x-ray crystal structure of HIV-1 protease complexed with a hydroxyethylene inhibitor. Graves BJ; Hatada MH; Miller JK; Graves MC; Roy S; Cook CM; Kröhn A; Martin JA; Roberts NA Adv Exp Med Biol; 1991; 306():455-60. PubMed ID: 1812742 [No Abstract] [Full Text] [Related]
37. Acquired Removability of Aspartic Protease Inhibitors by Direct Biotinylation. Hidaka K; Adachi M; Tsuda Y Bioconjug Chem; 2019 Jul; 30(7):1979-1985. PubMed ID: 30990716 [TBL] [Abstract][Full Text] [Related]
38. Among the devils in the details are protease sequence, susceptibility, and structure in CRF02_AG viruses. Katzenstein D; Ogden R Clin Infect Dis; 2005 Jul; 41(2):252-4. PubMed ID: 15983924 [No Abstract] [Full Text] [Related]
39. Comparison of three inhibitor complexes of human immunodeficiency virus protease. Swain AL; Gustchina A; Wlodawer A Adv Exp Med Biol; 1991; 306():433-41. PubMed ID: 1812740 [No Abstract] [Full Text] [Related]
40. Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation. McPhee F; Good AC; Kuntz ID; Craik CS Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11477-81. PubMed ID: 8876160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]